The Mouse Mammary Carcinoma 4T1: Characterization of the Cellular Landscape of Primary Tumours and Metastatic Tumour Foci
Overview
Affiliations
The murine mammary carcinoma 4T1 causes a leukemoid reaction with profound granulocytosis coincident with the production of tumour-derived growth factors. Here, we study the evolving cellular landscape of primary tumours and metastatic tumour foci and correlate haematopoietic cell infiltration with the production of tumour-derived chemokines. Flow cytometric analysis of enzyme digested primary tumours at different times after transplantation revealed a progressively increasing CD45(+) haematopoietic cell infiltrate consisting predominantly of CD11b(+) myeloid cells. Most of these cells had an F4/80(+)/CD11c(+) phenotype, many of which also stained Gr-1(+). Smaller numbers of Gr-1(+)CD11b(+) granulocytes and lymphoid cells were also identified. Progressive increases in Gr-1(+) granulocytes were observed in enzymatic digests of livers and lungs with metastatic tumour foci. Cultured 4T1 tumour cells expressed mRNA transcripts for the myeloid cell chemokines RANTES, MCP-1 and KC, and enzymatically digested cells from primary 4T1 tumours partially depleted of CD45(+) cells expressed transcripts for these chemokines and also MIP-1alpha and MIP-1beta. These data demonstrate that 4T1 tumour-bearing mice have mixed myeloid cell infiltrates of primary tumours and granulocytic infiltrates of metastatic organs. This pathologic presentation correlated with the expression of tumour-derived chemokines.
Canine, Feline, and Murine Mammary Tumors as a Model for Translational Research in Breast Cancer.
Cassali G, Nakagaki K, Salvi M, Dos Reys M, Rocha M, de Campos C Vet Sci. 2025; 12(2).
PMID: 40005948 PMC: 11860833. DOI: 10.3390/vetsci12020189.
Shah J, Siebert J, Zhao X, He S, Riman R, Tan M Adv Nanobiomed Res. 2024; 4(2):2300092.
PMID: 39554690 PMC: 11566364. DOI: 10.1002/anbr.202300092.
Kim M, Powers C, Fisher D, Ku A, Neznanov N, Safina A Cancers (Basel). 2024; 16(21).
PMID: 39518148 PMC: 11545300. DOI: 10.3390/cancers16213711.
Bone mineral density affects tumor growth by shaping microenvironmental heterogeneity.
Whitman M, Mantri M, Spanos E, Estroff L, De Vlaminck I, Fischbach C Biomaterials. 2024; 315:122916.
PMID: 39490060 PMC: 11658005. DOI: 10.1016/j.biomaterials.2024.122916.
Souza J, Antunes-Porto A, da Silva Oliveira I, Amorim C, Pires L, de Brito Duval I Sci Rep. 2024; 14(1):26476.
PMID: 39488625 PMC: 11531515. DOI: 10.1038/s41598-024-77126-x.